AI assistant
Iridium Communications Inc. — Director's Dealing 2021
Feb 19, 2021
31757_dirs_2021-02-19_bcc9aa00-56e8-4197-8681-de64eaa4b6ce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Iridium Communications Inc. (IRDM)
CIK: 0001418819
Period of Report: 2021-02-17
Reporting Person: FITZPATRICK THOMAS (Director, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-17 | Common Stock | S | 25395 | $47.79 | Disposed | 138113 | Direct |
| 2021-02-17 | Common Stock | S | 45195 | $48.44 | Disposed | 92918 | Direct |
| 2021-02-17 | Common Stock | S | 600 | $49.22 | Disposed | 92318 | Direct |
| 2021-02-18 | Common Stock | M | 79681 | $6.08 | Acquired | 171999 | Direct |
| 2021-02-18 | Common Stock | M | 90909 | $6.25 | Acquired | 262908 | Direct |
| 2021-02-18 | Common Stock | S | 60001 | $46.59 | Disposed | 202907 | Direct |
| 2021-02-18 | Common Stock | S | 110589 | $47.26 | Disposed | 92318 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-18 | Employee Stock Option (Right to Buy) | $6.08 | M | 79681 | Disposed | 2023-03-01 | Common Stock (79681) | Direct |
| 2021-02-18 | Employee Stock Option (Right to Buy) | $6.25 | M | 90909 | Disposed | 2024-01-01 | Common Stock (90909) | Direct |
Footnotes
F1: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $47.15 to $48.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F2: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $48.15 to $49.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F3: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $49.16 to $49.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F4: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $45.99 to $46.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F5: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $46.99 to $47.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F6: 25% of the shares of common stock underlying the option vested and became exercisable on March 1, 2014 and quarterly thereafter in equal installments on June 1, September 1 and December 1, so that all shares of common stock underlying the option fully vested and became exercisable on March 1, 2017.
F7: 25% of the shares of common stock underlying the option vested and became exercisable on January 1, 2015 and quarterly thereafter in equal installments on April 1, July 1 and October 1, so that all shares of common stock underlying the option vested and became exercisable on January 1, 2018.